AAI Vanguard Award Lecture Presenters

Formerly AAI Minority Affairs Committee (MAC) Guest Lecture

Since 2003, the AAI Annual Meeting has featured a scientific lecture sponsored by the AAI Minority Affairs Committee. The lecture series features AAI members who are underrepresented scientists, i.e., those from racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented in health-related sciences on a national basis. Following are past AAI Vanguard (MAC Guest) Lecturers.

Note: lecturers' institutional affiliations reflect their affiliations at the time of their AAI presentation.


Robert J. Binder, Ph.D.
Univ. of Pittsburgh
Key pathways in immunosurveillance of cancer


Cherié L. Butts, Ph.D.
Concept to approved drug: why immunologists are critical when developing new medicines


De’Broski R. Herbert, Ph.D.
Univ. of Pennsylvania Sch. of Vet. Med.
IL-33 regulates the balance between inflammation and immunosuppression


Margaret S. Bynoe, Ph.D.
Cornell University College of Veterinary Medicine
Adenosine receptor axis in blood brain barrier (BBB) permeability regulation


Elina Zúñiga, Ph.D.
University of California, San Diego
The art of coexistence: immune adaptations during chronic viral infections


Tyler J. Curiel, M.D., M.P.H.
The University of Texas Health Science Center at San Antonio
Advancing towards optimized cancer immunotherapy


Prosper N. Boyaka, Ph.D.
Ohio State University
Diversity: Lessons from regulation of mucosal immunity by toxins and microbiota


Gabriel Núñez, M.D.
University of Michigan
Linking pathogen virulence, immunity, and the microbiota


Arturo Casadevall, Ph.D.
Albert Einstein College of Medicine, Yeshiva University
A new synthesis for antibody-mediated immunity


Esteban Celis, Ph.D.
Moffitt Cancer Center, University of South Florida
The long road to effective peptide vaccines for cancer: learning from infectious diseases and autoimmunity


Charles E. Egwuagu, M.P.H., Ph.D.
National Eye Institute, National Institutes of Health
Regulation of autoreactive lymphocytes that mediate CNS autoimmune diseases


Olivia M. Martinez, Ph.D.
Stanford School of Medicine
Effects of viral proteins on lymphocyte function in Epstein Barr Virus B cell lymphomas


Albert Zlotnik, Ph.D.
University of California, Irvine
An evolutionary view of chemokines


Emil R. Unanue, M.D.
Washington University School of Medicine
The mysteries of peptide selection by the class II MHC molecules


Juan J. Lafaille, Ph.D.
New York University School of Medicine
Antigen-induced Foxp3+ regulatory T cells


Avery August, Ph.D.
Pennsylvania State University
Tec tyrosine kinase modulation of airway responses


Diana M. Lopez, Ph.D.
University of Miami
A unique mucin immunoenhancing peptide with anti-tumor properties


Juan Carlos Zúñiga-Pflücker, Ph.D.
Sunnybrook and Women’s Research Institute, University of Toronto
Becoming a T cell: lineage options and decisions by stem cells


Randy R. Brutkiewicz, Ph.D.
Indiana University School of Medicine
CD1d-mediated antigen presentation to NKT Cells


Richard A. Goldsby, Ph.D.
Amherst College
Human antibody from human artificial chromosome transgenic cloned cattle

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
(301) 634-7178 | infoaai@aai.org